Technical Analysis for BABY - Natus Medical Incorporated

Grade Last Price % Change Price Change
grade F 25.2 -6.25% -1.68
BABY closed down 6.25 percent on Friday, March 22, 2019, on 54 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical BABY trend table...

Date Alert Name Type % Chg
Mar 22 New 52 Week Closing Low Bearish 0.00%
Mar 22 Stochastic Reached Oversold Weakness 0.00%
Mar 22 Below Lower BB Weakness 0.00%
Mar 22 Lower Bollinger Band Touch Weakness 0.00%
Mar 22 Oversold Stochastic Weakness 0.00%
Mar 21 Pocket Pivot Bullish Swing Setup -6.25%
Mar 20 Down 3 Days in a Row Weakness -4.73%
Mar 19 Narrow Range Bar Range Contraction -5.79%
Mar 19 NR7 Range Contraction -5.79%
Mar 18 20 DMA Resistance Bearish -6.74%

Older signals for BABY ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Natus Medical Incorporated provides neurodiagnostic and newborn care products worldwide. The company offers healthcare products used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Its product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and incubators to control the newborn's environment; and software systems for managing and tracking disorders and diseases. The company provides newborn hearing screening product lines consisting of the ALGO, ABaer, AuDX, and Echo-Screen newborn hearing screeners; and hearing screening supply products that are used with newborn hearing screening devices. It also offers diagnostic hearing assessment product lines, which include the Navigator Pro system, the Scout sport portable diagnostic device, and the AuDX PRO; and diagnostic hearing supply products. In addition, the company provides monitoring systems, balance and mobility products, newborn brain injury diagnostic products, thermoregulation products, and jaundice management products. Further, it offers photometers, radiometers, patient warming lamps, neonatal heatshields, pediatric scales, blanket warming cabinets, exam lights, oxygen hoods, restraining boards, and newborn circumstraints; neonatal noise attenuators, phototherapy eye masks, and x-ray shields for reproductive organs; and newborn screening data management products. The company serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was founded in 1987 and is headquartered in San Carlos, California.
Medicine Health Diseases Disorders X Ray Epilepsy Healthcare Products Sleep Disorders Software Systems Hearing Loss Mobility Products Light Therapy Monitoring Systems Neonatology Newborn Screening
Is BABY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 37.95
52 Week Low 25.06
Average Volume 454,666
200-Day Moving Average 33.0259
50-Day Moving Average 29.8618
20-Day Moving Average 27.1545
10-Day Moving Average 26.731
Average True Range 0.8378
ADX 38.09
+DI 15.0655
-DI 34.145
Chandelier Exit (Long, 3 ATRs ) 26.1866
Chandelier Exit (Short, 3 ATRs ) 27.7134
Upper Bollinger Band 28.6711
Lower Bollinger Band 25.6379
Percent B (%b) -0.14
BandWidth 11.170156
MACD Line -0.9052
MACD Signal Line -0.9451
MACD Histogram 0.0399
Fundamentals Value
Market Cap 818.77 Million
Num Shares 32.5 Million
EPS 0.58
Price-to-Earnings (P/E) Ratio 43.45
Price-to-Sales 2.93
Price-to-Book 3.06
PEG Ratio 1.06
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 27.54
Resistance 3 (R3) 27.80 27.28 27.15
Resistance 2 (R2) 27.28 26.68 27.15 27.02
Resistance 1 (R1) 26.24 26.32 25.98 25.98 26.89
Pivot Point 25.72 25.72 25.59 25.59 25.72
Support 1 (S1) 24.68 25.12 24.42 24.42 23.51
Support 2 (S2) 24.16 24.76 24.03 23.38
Support 3 (S3) 23.12 24.16 23.25
Support 4 (S4) 22.86